Life Course, HIV and Hepatitis B Among African Migrants Living in Ile-de-France
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 2,468
- 主要终点
- Lapse of time from arrival in France to HIV testing
研究概览
简要总结
Populations from Sub-Saharan Africa represent one of the most dynamic immigration flows in France and are among the most exposed to HIV infection and hepatitis B.
The Parcours study aims to understand, among sub-Saharan African migrants, how social and individual factors combine in the course of migration and settlement in France, and influence the risk of infection, access to prevention and care, and the effectiveness of care for both HIV and hepatitis B diseases.
The research was conducted in Ile-de-France, where 60% of sub-Saharan African migrants reside. It consists in a cross-sectional observational survey, using a life-event history approach that reproduces the sequence of different life and health events, and contributes to explain the present situation (type of disease management, patient's quality of life) in light of all the elements of the past trajectory (administrative, familial, socio-economic, professionals).
A representative survey was conducted between February 2012 and May 2013 in health care facilities in Ile-de-France, among three groups of migrants from Sub-Saharan Africa: a group living with HIV, a group living with chronic hepatitis B and a group who has neither of these diseases. For each group, stratified random sampling was used. The survey was conducted in 24 hospital services providing HIV care, 20 health care facilities providing hepatitis B care, and 30 primary health care facilities.
Were eligible all patients attending these health care facilities, born in a Sub-Saharan African country and with Sub-Saharan African citizenship at birth, aged 18 to 59 years, with an HIV diagnosis (HIV group) or chronic hepatitis B diagnosis (hepatitis B group) more than three months prior or not diagnosed with HIV or chronic Hepatitis B (reference group).
Among the patients offered participation, 926 HIV-infected patients, 779 patients infected by hepatitis B, and 763 patients without these two diseases participated in the study.
For all participants, detailed information on socio-demographic characteristics; migration and life conditions in France; social, sexual and reproductive life history; and screening and care history were collected using a life-event history questionnaire administered face-to-face by a specialized interviewer. Health care professionals documented clinical information from the medical records. Data was collected anonymously.
详细描述
The PARCOURS study was conducted to study how health trajectories and social and migratory paths are interlaced for migrants from sub-Saharan Africa living in France. This retrospective quantitative life-event survey was conducted from February 2012 to May 2013 in health-care facilities in the greater Paris metropolitan area (Ile-de-France), among three groups of migrants born in sub-Saharan Africa: one group receiving HIV care, one group with chronic hepatitis B, and a third group of people visiting primary-care centres. Recruitment took place at facilities randomly selected from an exhaustive list of HIV outpatient hospital clinics (n=24), hepatitis treatment clinics (n=20) and general practice medical centres (n=30).
Recruitment procedure for patients in each group:
Within each health care facility selected for the study, all health care professionals providing outpatient care to patients born in sub-Saharan Africa were asked to participate in the study. They identified eligible patients during consultations based on medical records, and offered study participation to all eligible patients, except when the patient was deemed unable to be interviewed (for mental health or physical health reasons or because were unable to be interviewed in one of the languages spoken by the interviewer). When the patient agreed to participate in the study, health care professionals gave her/him an information leaflet on the study and obtained written consent. They also gave the participant a card bearing an identification number to ensure data collection anonymity and confidentiality, and referred her/him to the Parcours interviewer at the end of the consultation. The Parcours interviewer conducted the interview right after the consultation, in face-to-face mode, in a dedicated room, with closed door to ensure privacy.
The health care professional could also suggest an appointment in the following days, always on site, to patients who agreed to participate in the study but were not immediately available.
Consideration of non-Francophone participants:
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 59 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •- For the 3 groups:
- •Be born in a Sub-Saharan African country and with Sub-Saharan African citizenship at birth,
- •Visit the health care facility for one's own health.
- •For the HIV group: To have been diagnosed for HIV more than 3 months ago, regardless of co-infections
- •For the hepatitis B group: To have been diagnosed with a chronic hepatitis B (AgHBs+) more than 3 months ago and not be HIV co-infected
- •For the primary care group: Not be known by the consulting physician as infected by HIV or Hepatitis B.
排除标准
- •to have been diagnosed for HIV or hepatitis B less than 3 months ago.
- •major cognitive or health impairments
结局指标
主要结局
Lapse of time from arrival in France to HIV testing
时间窗: From arrival in France until the date of first HIV testing or date of of data collection, whichever came first, up to 20 years
Time (in years) to occurence of first HIV testing, from arrival in France
Lapse of time from hepatitis B diagnostic to access to care
时间窗: From first hepatitis B diagnostic until the date of entry into care for hepatitis or date of of data collection, whichever came first, up to 20 years
Time (in years) to occurence of entry into Hepatitis B care, from hepatitis B diagnostic
Lapse of time from arrival in France to hepatitis B testing
时间窗: From arrival in France until the date of first hepatitis B testing or date of of data collection, whichever came first, up to 20 years
Time (in years) to occurence of first hepatitis B testing, from arrival in France
Lapse of time from HIV diagnostic to access to care
时间窗: From first HIV diagnostic until the date of entry into care for HIV or date of of data collection, whichever came first, up to 20 years
Time (in years) to occurence of entry into HIV care, from HIV diagnostic
次要结局
- Evolution in occasional sexual partnerships after migration in France(At arrival in France, and then each year up to 20 years after arrival in France)
- Evolution in concurrent sexual partnerships after migration in France(At arrival in France, and then each year up to 20 years after arrival in France)
- Condom use(twelve months before data collection)
- Evolution in transactional sexual partnerships after migration in France(At arrival in France, and then each year up to 20 years after arrival in France)